Diversity of Multidrug Efflux Genes and Phenotypic Evaluation of the In vitro Resistance Dynamics of Clinical Staphylococcus Aureus Isolates Using Methicillin; a Model β-lactam
John F. Antiabong, Marleen M. Kock, Nontombi M. Mbelle, Marthie M. Ehlers*
Identifiers and Pagination:Year: 2017
First Page: 132
Last Page: 141
Publisher Id: TOMICROJ-11-132
Article History:Received Date: 30/12/2016
Revision Received Date: 17/04/2017
Acceptance Date: 23/04/2017
Electronic publication date: 30/06/2017
Collection year: 2017
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Methicillin-resistant Staphylococcus aureus (MRSA) across the world often leave clinicians with little or no choice of treatment options. The multi-drug efflux (MDE) genes are bacterial survival mechanisms responsible for the pumping out of antibiotics and other biocides from the cytoplasm. Whilst effort is being made in the development of antibiotic adjuvants such as efflux pumps inhibitors, information is needed on the diversity of these MDEs in the circulating S. aureus and on the growth dynamics of the clinical isolates in response to antibiotics is not regularly examined.
Here, we evaluated the diversity of MDEs in cinical S. aureus recovered in a tertiary academic hospital, Pretoria, South African hospital using PCR and also employed visual minimum inhibitory concentration and quantitative analysis of spectrophometric measurements of bacterial growth in the presence of a model β lactam antibiotic (methicillin), to phenotypically elucidate the resistance pattern of these isolates in response to methicillin.
Three major distribution patterns of MDEs were observed in the clinical isolates evaluated. Moreover, norA, nor B and tet38 were present in 98.9% of the isolates while other MDE were present in different proportions ranging from 40 to 98.6% of the isolates. In addition, S. aureus isolates, be it of MRSA or MSSA genotype did not habour the same set of MDEs despite being recovered from the same hospital setting. Finally, we showed that MSSA displayed phenotypic resistance to methicilllin despite the non-detection of the mecA resistance gene.
Our data suggest that the growth of S. aureus may be enhanced by β lactams (methicillin) and that MSSA may also display resistance to methicillin and perhaps other β lactam antibiotics. The high prevalence of MDEs suggestive of resistance to a broad spectrum of biocides and fluoroquinolones are particularly disturbing.
MRSA is a Gram positive bacterium with a circular chromosome of 2.2-2.8 Mbp and varieties of extra-chromosomal elements that include plasmids, phages and other mobile elements . The genome of S. aureus encodes chromosomal and extra-chromosomal virulence determinants, antibiotic resistance genes and multi-drug efflux genes (MDE) which play significant roles in the pathogenesis of S. aureus-associated infections and poor antibiotic therapeutic outcome ; thereby increasing patient suffering and sustained epidemics.
The MDE genes are bacterial survival mechanisms responsible for pumping out antibiotics and other biocides from the cytoplasm . These efflux pumps can either be chromosomal or plasmid encoded and are able to extrude specific and/or different classes of antimicrobial compounds including biocides . The MDEs are grouped into five families based on their structure and the kinetics of their activities: (i) the major facilitator superfamily (MFS), (ii) the small multi-drug resistance (SMR) family, (iii) the multi-drug and toxic compound extrusion (MATE) family, (iv) the resistance-nodulation-cell division (RND) superfamily and (v) the adenosine-triphosphate (ATP)-binding cassette (ABC) superfamily. Several MDEs have been described in S. aureus Table (S1) that contribute to the antimicrobial resistance mechanisms in this pathogen .
Previous studies have reported the prevalence and diversity of clinical MRSA isolate in Pretoria, South Africa [4, 5]. However, there are no reports on the distribution patterns of the multidrug efflux genes of the clinical isolates in South Africa. In addition, studies on antimicrobial profiling of S. aureus isolates often report the minimum inhibitor concentrations (MIC) of the tested antimicrobial and neglect the evaluation of the growth dynamics of the isolates; an assessment that could provide insight into the growth characteristics of the pathogen in response to antibiotics. This report reveals that all S. aureus isolates, be it of MRSA or MSSA genotype, do not contain the same set of MDEs despite being isolated from the same hospital setting and that there are at least four groups of specific growth-response pattern showing resistance to the model I lactam antibiotic, methicillin.
MATERIALS AND METHOD
Experimental Design Rationale
The clinical use of methicillin as antibiotics has been halted in many countries due to the development of resistance by microbes to this antimicrobial agent. However, this phenomenon makes it a useful tool in unravelling the resistance mechanisms to β lactam antibiotics for the following reasons: (a) Methicillin forms the chemical backbone for modern β lactam antibiotics. (b) Most clinical S. aureus isolates are likely to develop resistance to this chemical agent due to the presence of mecA gene in MRSA or due to exposure to modern β lactam antibiotics sharing similar chemical structure (c) Methicillin is insensitive to the S. aureus encoded beta lactamase  thus, making it possible to rule out the effect of antibiotic degradation. The MDEs investigated in this study are limited to those reported in Costa et al.  and covers the main classes of MDEs so far identified in S. aureus Table (1).
Ninety-seven previously characterized Staphyloccocal isolates were obtained from the Diagnostic Laboratory, Department of Medical Microbiology, University of Pretoria Tshwane Academic Division, National Health Laboratory Service, South Africa. These consisted of 81 MRSA and 16 MSSA isolates. The specimen were collected from Tshwane Academic Hospital in Pretoria, South Africa with Research Ethics Approval (protocol number 394/2014) from the Faculty of Health Sciences, University of Pretoria.
Total Bacterial DNA Purification
Total bacterial DNA purification. Each isolate was plated out on blood agar to ensure the purity and a single colony inoculated in Brain heart infusion (BHI) broth (Oxoid, England) and incubated (Scientific Incubator, Vacutec, South Africa) at 37˚C for 24 h.
The genomic DNA from individual isolates was extracted using the ZR Fungal/Bacterial DNA Miniprep (Zymo Research Corporation, USA) according to the manufacturer’s instruction and the specific genes encoding multi-drug efflux genes were detected by multiplex-PCR using target-specific primers (Table 1).
The amplification of the target genes was performed in a 25 µl reaction mix (Table S2) using a cycliplex PCR strategy  which involves a single optimized-PCR condition that allows multiplexing of different gene target-primer sets in different PCR tubes and run at once thereby saving time (Table S2). The identity of each isolates as MRSA or MSSA was reconfirmed by PCR detection of the S. aureus mecA genes as previously described [4, 8]. To assess the general PCR performance, the eubacterial 16S rDNA V3 region was also targeted in each batch of PCR run as described previously .
|Primer code/target gene||Sequence (5' to 3')*||Amplicon size||Reference|
|qacA/B (F)||CTATGGCAATAGGAGATATGGTGT||321 bp||(24)|
|qacC (F)||AACAATGCAACACCTACCACT||157 bp||(24)|
|smr (F)||CTATGGCAATAGGAGATATGGTGT||417 bp||(25)|
|norA (F)||TTCACCAAGCCATCAAAAAG||95 bp||(26)|
|norB (F)||AGCGCGTTGTCTATCTTTCC||213 bp||(27)|
|norC (F)||AATGGGTTCTAAGCGACCAA||216 bp||(27)|
|mepA (F)||TGCTGCTGCTCTGTTCTTTA||198 bp||(27)|
|mdeA (F)||GTTTATGCGATTCGAATGGTTGGT||155 bp||(28)|
|sepA (F)||GCAGTCGAGCATTTAATGGA||103 bp||(27)|
|lmrS (F)||TGCAGTTAAATGCGATGGCG||135 bp||This study|
|sdrM (F)||GGCAATGATCGCAATCGGTA||126 bp||This study|
|tet38 (F)||AGTTGGCAAGCGACATTAGC||212 bp||This study|
|314F (Eubacteria 16S rDNA V3 region)||CCTACGGGAGGCAGCAG||200 bp||(29)|
|518R (Eubacteria 16S rDNA V3 region)||ATTACCGCGGCTGCTGG|
All PCR amplicons were fractionated in 2.5% agarose gel (NuSieve ™ GTG ™ agarose, Whitehead scientific, South Africa) and visualized under UV light for digital documentation. A 100 bp DNA ladder (Thermo Scientific, South Africa) was included in the electrophoresis run for estimation of the amplicon size. The distribution of the MDEs in each isolate was recorded.
Determination of Minimum Inhibitory Concentration (MIC), Susceptibility Concentration (SC) and Bacteria Growth Dynamics
A total of 24 isolates consisting of a minimum of two isolates from a cluster of MRSA or MSSA as determined by UPGMA (Unweighted Pair Group Method with Arithmetic Mean) clustering of the MDEs distribution in each isolate Fig. (S1), were used for this assay. Single outliers that did not cluster with any other isolate were also included. The methicillin (Sigma Aldrich; South Africa) SCs for the 24 clinical MRSA and MSSA isolates were determined using the micro-dilution method as described in the Clinical and Laboratory Standards Institute (9). Briefly, 5 X 104 CFU/ml of each isolate was incubated in Tryptone soya broth (Oxoid, South Africa) in the presence of 0.5, 1, 2, 4, 8 and 16 µg/ml methicillin for 16 hr at 37 ˚C. The visual SCs were defined as susceptible (no visual growth observed); resistant (micro-well completely covered with bacteria; and intermediate resistance (about 1-4 dot-like growth observed in the micro-well). Two independent tests were performed to assess reproducibility. The MIC was taken as the minimum concentration in which no visual bacterial growth was observed. The growth of the 24 S. aureus isolates was also determined by quantitative analysis of spectrophotometric measurements of the optical density (absorption) at 600nm after the 16 h incubation period. The S. aureus MU50 ATCC 700699 was used as control in the spectrophotometric measurements.
The distribution pattern of MDEs in each MRSA/MSSA and the growth dynamics of representative isolates were evaluated using a UPGMA (Unweighted Pair Group Method with Arithmetic Mean) dendrogram constructed by hierarchical clustering with a Jaccard Tanimoto co-efficient and a distance value estimated using the formula d = (1-r) X 100. The results are presented in a table format for clarity.
A correlation statistics of the co-existence of MDEs in the MRSA and MSSA isolates was determined by Pearson’s correlation with p ≥ 0.05 and the result rendered as a heatmap matrix with the aid of Plotly, an open source program (https://plot.ly/).
Diversity and Distribution Pattern of MDEs in Clinical S. aureus Isolates
In other to evaluate the distribution pattern of the MDEs, all the isolates were reconfirmed as MRSA or MSSA and the PCR strategy used for the MDEs used proved to be robust and showed distinct and clear bands on the electrophoretic gel (Fig. S2). The distribution pattern of the detected MDEs in the clinical MRSA and MSSA isolates clustered into three major groups (Fig. S1 and Table S3). All the 11 MDE genes assessed in this study were detected in 35.05% (34/97) of the total isolates; out of which, 8.82% (3/34) were MSSA. The smr and qacA/B genes were not detected in 31.96% (31/97) of the all isolates, which, however; harboured nine other MDEs. The MSSA represented 16.1% (5/31) of this cluster. Moreover, MDEs including norC, sdrM and qacA/B were not detected in 12.37% (12/97) of the isolates, which hitherto had 8 other MDEs. This cluster included 50%(6/12) MSSA isolates. Other clusters/outliers included isolates numbers ranging from 1-4 and made up to 21.2% of the total S. aureus isolates. We did not observe any correlation between the genomic location (chromosomal or plasmid) of the MDEs and their distribution pattern in all the isolates.
A strong positive correlation (Pearson coefficient =1) was observed for the co-existence of norA, norB and tet38 efflux genes. This was followed by qacA/B and smr (Pearson coefficient = 0.89) which were present in 41.24% (40/97) and 44.33% (44/97) of the isolates, respectively (Table S4). Weak negative correlations were also observed for the co-existence of tet38 and other MDE genes including norA, norB and qacA/B (Table S4). Heatmap matrix Fig. (1) revealed the tendency of norC, sdrM, smr and qacA/B to be co-absent in some S. aureus strains especially in the MSSA (Table S5).
The observed individual prevalence of the other MDEs evaluated included norA (98.9%; 96/97); norB (98.9%; 96/97); mepA (97.9%; 95/97); tet38 (98.9%; 96/97); sepA (96.9%; 94/97); MdeA (95.9%; 93/97); lmrs (88.7%; 86/97); sdrM (85.6%; 83/97) and norC (79.4%; 77/97) (Table S5).
Cluster-Dependent Heterogenic Growth Response to Methicillin and Co-Clustering of Clinical MRSA and MSSA Isolates in Relation to Their Growth Dynamics in the Presence of Methicillin
Hierarchical clustering based on the spectrophotometric measurement of the growth of clinical S. aureus isolates in the presence of different concentration of methicillin, revealed two major clusters made up of four groups which showed heterogeneity in their response to methicillin Fig. (2A). Moreover, MRSA and MSSA isolates co-clustered (Fig. 2B); Groups 3 and 4) in relation to their growth trend. Assessment of the individual MRSA and MSSA isolates within the co-clusters showed that they had similar growth-response phenotype (Fig. 3). However, MRSA isolates exclusively made up other clusters (Fig. 2B); Groups 1 and 2). There was no correlation between the specimen type or the hospital unit where the specimen were collected (Table S6).
The phenotypic characteristics of the four groups are as follows: Group 1: Those that were resistant at all tested concentrations of methicillin and therefore showed no dose-dependent difference in the level of growth. Group 2: Those that showed typical dose-dependent growth reduction in the presence of methicillin. Group 3: Those that appeared to display a growth trend that was directly proportional to the methicillin dose increment from 1-16 µg/ml. The S. aureus MU50 ATCC 700699 was clustered in this group. Group 4: Isolates that showed similar growth trend were observed in Group 3, however, with a lower average growth.
Correlation analysis of quantitative spectrophotometric growth measurements and the distribution of MDEs in the 24 S. aureus isolates revealed no specific correlation between the distribution pattern of MDEs and the concentrations of methicillin tested in this study (Data not shown).
Evaluation of Visual SCs.
Visual SC determination of the 24 representative S. aureus isolates (based on the MDE distribution pattern) showed that two (11.8%; 2/17) MRSA and two (28.6%; 2/7) MSSA isolates had an MIC of 0.5 µg/ml; two (11.8%; 2/17) MRSA and MSSA isolates had MIC of 2 µg/ml respectively, while two (28.6%; 2/7) MSSA isolates had an MIC of 4 µg/ml Table (2). As expected, most of the MRSA (76.5%; 13/17) isolates were resistant to methicillin while the MSSA isolates (57.1%; 4/6) were susceptible. Intermediate resistance (1-4 spots of bacterial growth in the micro-wells) ranging from 8-16 µg/ml was observed in two (11.8%; 2/17) of the representative MRSA isolates. Intermediate resistance ranging from 1-16µg/ml was observed in four (50%; 4/8) of the MSSA (Table S4).
|Isolates ID†||16 µg/ml||8 µg/ml||4 µg/ml||2 µg/ml||1 µg/ml||0.5 µg/ml|
Staphylococcus aureus-associated diseases remain a threat to human and animal health. Methicillin-resistant Staphylococcus aureus (MRSA) across the world often leave clinicians with little or no choice of treatment options [9, 10]. As the genetic diverity of this pathogen increases [11, 12] and fewer new antibiotics are entering into clinical use, efforts are being renewed to boost the activity of old antimicrobials to which pathogens have developed resistance. These efforts include the implementation of antibiotic stewardship which includes strategic use of antibiotics  and the development of antibiotic adjuvants such as efflux pumps inhibitors to counter resistance and/or enhance the activity of antibiotics in clinical use .
To contribute to this effort, this study revealed three major clusters of MDE distribution patterns in the clinical S. aureus isolates obtained from a hospital in South Africa suggesting that all members of the same bacterial species may not contain the same MDEs as previously suggested .
The prevalence of qacA/B gene in this study (35.08%) is higher compared to that reported in a Japanese hospital (23.6%) (16). Moreover, smr gene which has a lower activity compared to qacA/B gene (2) was present in 43.3% of the isolates and higher in prevalence compared to that of the Japanese study (4.2%) .
|Fig. (3). Homogenous response pattern to methicillin by MRSA and MSSA. The lines linking each methicillin concentration indicate polynomial trends of the bacterial growth. Isolates IDs with TA indicate MRSA while SA indicate MSSA.|
It has been shown that most efflux pumps inhibitors have been focused on norA . The observations in this study indicate the importance of expanding this effort to cover other MDEs. Moreover, the detection of norA, norB norC, mepA and sdrM in all the isolates corroborates with the focus on these important MDE efflux pumps and suggest the potential for resistance to flouroquinolones incuding norfloxacin, ciprofloxacin and sparfloxacin [2, 14]. Our laboratory is looking for the possible correlation between the presence of these genes and resistance to flouroquinolones.
The high prevalence of mdeA, sepA, and mepA is particularly worrisome and suggests a high risk of resistance to a wide range of commonly used antiseptics, biocides and antibiotics of different chemical class . Similarly, tet38 which is involved in the extrusion of tetracycline  was absent only in one MRSA isolate indicating a high prevalence of this gene in the S. aureus isolated from patients attending the health care facility.
Interestingly, we found an isolate (TA162) which harboured only qacA/B and smr (Table S3). Repeated PCR assays indicated a consistent result for this isolate. It is not known whether this was due to mutations in the genes that prevented primer recognition of target sites in this isolate or this isolate simply evolved differently from the other isolates tested in this study. Further assessment of this isolate is the next step to be followed in our laboratory. Moreover, this study showed the co-existence and co-absence of some MDEs in the S. aureus strains suggesting a possible co-evolution of these genes in the pathogens. It is not certain if the co-absence of norC, sdrM, smr and qacA/B in the MSSA strains plays a role in susceptibility to antibiotics compared to the MRSA.
Although it is not known what factor drives the different distribution of efflux genes in the S. aureus isolates in this study, it is thought that antibiotic resistance is a natural ecological phenomenon resulting from years of evolutionary process that may include a combination of different mechanisms .
It has been suggested that MDEs may also play a role in virulence of bacteria as these factors assist in colonization of the host tissue by removing host bile salts and antimicrobial peptides that may prevent colonization process [18-20]. The finding of different distribution patterns in individual isolates begs the question of ‘what roles do the different distribution patterns have in these isolates? Pearsons correlation analysis suggested that none of the combinations of MDEs evaluated in this study had an obvious effect on the β-lactam, methicilin. However, the effect of individual MDE on the resistance pattern could not be assessed using this experimental design. No correlation was observed between the MDEs distribution pattern in an isolate and SCCmec type (Data not shown).
By evaluating the visual MIC, SC and the growth dynamics in the presence of methicilin, the resistance phenotype of the clinical MRSA and MSSA isolates could be determined. Importantly, some MRSA and MSSA isolates demonstrated similar susceptibility even at 0.5 µg/ml methicilin, or resistance at concentration as high as 16 µg/ml (Fig. 2). This suggest that despite the lack of mecA genes in MSSA isolates, phenotypic resistance characteristics should not be overlooked in clinical settings.
Similarly, phenotypic assessment of the resistance mechanism in the clinical S. aureus isolates using spectrophotometric measurements of the growth in TSB media, showed two major clusters consisting of four groups of specific growth-response pattern showing the resistance to the model β lactam antibiotic, methicillin. The clustering of the well characterized S. aureus MU50 ATCC 799600 to Group 2 which showed a dose-dependent response in contrast to other groups (Fig. 2A) clearly showed that there exist phenotypic differences in the resistance pattern of clinial MRSA to methicilin and perhaps other β lactams with similar physicochemical properties. This quantitative analysis proved valuable in being able to reveal the growth dynamics of the isolates evaluated and showed that a group of isolates (Fig. 2B); Groups 3 and 4) actually had higher growth as the methicillin concentration increased. Another instance of the advantage provided by spectrophotometric bacterial growth measurement can be seen in Group 3 (Fig. 2A) in which isolates SA11, SA28, TA2, SA12, SA19 and TA41 showed increasing optical densities in response to higher concentrations (4-16 µg/ml) of methicillin, despite the fact that the MSSA isolates SA11, SA28 and SA12 were classified as susceptible at this concentrations (Table 2) based on the visual MIC assessment criteria for describing susceptibility as indicated in the method section. Interestingly, these isolates co-clustered with MRSA isolates TA41 and TA12 which displayed resistance at these concentrations thus indicating that the co-clustering was based mainly on the growth dynamics and independent of the genotype. These observations are contrary to reported hormesis effect where low doses of antibiotics are associated with increased bacterial growth [21, 22].
Subsistence of environmental bacteria on antibiotics has been previously reported . However, to our knowledge, this event has not been reported in clinical S. aureus isolates. Although it is not known if this observation was a result of direct utilization of methicillin as a carbon source or a trigger of other mechanisms that promote the bacterial growth, this observation represents a potential S. aureus resistance mechanism to methicilin and perhaps other β lactam antibiotics with similar structural and physicochemical properties. Theoretically, the clinical importance of these findings is that patients infected with these set of MSSA isolates may likely be prescribed/administered with antibiotic regimen that may not be able to kill the pathogen.
In conclusion, this study describes the diversity of MDEs in a hospital in South Africa and shows that there were at least three major distribution patterns of MDEs in the clinical isolates evaluated. This information is important for the development of antibiotic adjuvants that target the inhibition of MDE in S. aureus. In addition, we report that S. aureus isolates, be it of MRSA or MSSA genotype, do not contain the same set of MDEs despite being recovered from the same hospital setting. The high prevalence of MDEs suggestive of resistance to a broad spectrum of biocides and fluoroquinolones is particularly disturbing. A limitation of this study is the lack of CFU/mL data which would have shown the actual log increase or decrease in bacterial growth. However, a previous report demonstrated a strong correlation between optical density (absorption) measurement of S. aureus growth and CFU/mL [24-30]. Finally, at least four specific growth-response patterns of S. aureus in the presence of a model β lactam antibiotic (methicillin) were observed and included the enhancement of S. aureus growth in the presence of the antimicrobial agent.
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
HUMAN AND ANIMAL RIGHTS
No Animals/Humans were used for studies that are base of this research.
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
This study was funded by the National Research Council (MRC) and the National Research Foundation (NRF) of South Africa.